antileukemic

Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.

将白血病细胞与化药物微孔液体培养，MTT法检测细胞毒。

Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.

MRD抗白血病药物效标志,被用于评患者危险,在某些病例中也用于调强度。